Tiny blood samples, big clues: new study tracks brain health in preemies
NCT ID NCT07159555
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at levels of a brain protein called neurofilament in the blood of healthy late preterm babies (born at 34-37 weeks). Researchers want to know what normal levels are and how they change in the first weeks of life. Up to 15 newborns will provide extra blood during routine tests. The goal is to create a reference range that can help doctors better diagnose and treat nerve diseases like spinal muscular atrophy (SMA) in the future.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hopital Citadelle
RECRUITINGLiège, 4000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common antifungal change how an experimental drug acts?
- Can a new injection help tackle obesity? a safety trial begins
- Will a new pill formula absorb the same? a trial puts it to the test
- Can a new drug tame Alzheimer's? early trial aims to find out
- Could sitting too much alter your nervous system?
- Could a cancer drug alter Metformin's effects? a trial investigates